Zhang et al. [1] showed that ANRIL is not only associated with susceptibility to atherosclerosis and hemorrhagic stroke in stroke populations, but also independently predicts the risk of stroke recurrence and cardiovascular death. The gene discussed is CDKN2B-AS1; the disease is atherosclerosis.